ADC Therapeutics (ADCT) Net Margin (2019 - 2026)
ADC Therapeutics' Net Margin was -86.06% in Q2 2026, up 214.62 percentage points from -300.68% a year earlier and up 72.05 percentage points from the prior quarter.
Powered by 
Analysis
ADC Therapeutics (ADCT) Net Margin (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, ADC Therapeutics' Net Margin was -128.58% through Jun 30, 2026, up 90.00 percentage points year-over-year.
- The Q2 2026 figure marks the highest quarterly Net Margin since Q3 2022.
- Compared with a year earlier, Net Margin was higher in four of the last six quarters, with an average year-over-year change of +49.49 percentage points.
- The best year-over-year quarter for Net Margin over five years was Q2 2022 (a gain of 1557.73 percentage points); the worst was Q1 2023 (a drop of 276.79 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 19.55% |
| 10 | ADC Therapeutics | 192.88 Mn | -707.77 Mn | 19.74 Mn | -116.52% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -116.52% |
| Jun 30, 2026 | -86.06% |
| Mar 31, 2026 | -158.11% |
| Dec 31, 2025 | -27.80% |
| Sep 30, 2025 | -249.38% |
| Jun 30, 2025 | -300.68% |
| Mar 31, 2025 | -167.59% |
| Dec 31, 2024 | -181.71% |
| Sep 30, 2024 | -238.13% |
| Jun 30, 2024 | -209.90% |
| Mar 31, 2024 | -258.16% |
| Dec 31, 2023 | -506.44% |
| Sep 30, 2023 | -322.40% |
| Jun 30, 2023 | -253.71% |
| Mar 31, 2023 | -312.63% |
| Dec 31, 2022 | -36.51% |
| Sep 30, 2022 | -66.31% |
| Jun 30, 2022 | -372.30% |
| Mar 31, 2022 | -35.83% |
| Dec 31, 2021 | -202.12% |
API Access
ADC Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=ADCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "ADCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=ADCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();